Celldex Therapeutics CLDX
NASDAQ CLDX
$32.50 +0.86 (+2.72%)
As of: Sep 30, 2026 · 12:30 PM EDT

Celldex Therapeutics, Inc. (CLDX) Capital Expenditures (2010 - 2026)

Updated

Celldex Therapeutics' Capital Expenditures came in at $3.18 million for Q2 2026, up 336.7% from $728,000 a year earlier and up 94.0% from the prior quarter.

Analysis

Celldex Therapeutics, Inc. (CLDX) Capital Expenditures (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Capital Expenditures of $6.54 million, up 185.0% year-over-year; for FY2025, it was $2.71 million, up 41.4% from FY2024.

  • Capital Expenditures carries a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $1.92 million in FY2024 (+5.6%), $1.82 million in FY2023 (-0.5%), $1.83 million in FY2022 (+46.4%) and $1.25 million in FY2021 (-19.5%).
  • The Q2 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q3 2010.
  • Year-over-year, Capital Expenditures has increased for three consecutive quarters, with growth averaging 163.6% over the last eight quarters.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 518.5%), and the weakest in Q3 2023 (a decline of 54.5%).
  • Business Quant data shows CLDX's Capital Expenditures at $1.64 million (Q1 2026), $1.28 million (Q4 2025) and $440,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18 Mn
Mar 31, 2026 1.64 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 440,000.00
Jun 30, 2025 728,000.00
Mar 31, 2025 265,000.00
Dec 31, 2024 756,000.00
Sep 30, 2024 545,000.00
Jun 30, 2024 274,000.00
Mar 31, 2024 344,000.00
Dec 31, 2023 666,000.00
Sep 30, 2023 157,000.00
Jun 30, 2023 410,000.00
Mar 31, 2023 585,000.00
Dec 31, 2022 235,000.00
Sep 30, 2022 345,000.00
Jun 30, 2022 673,000.00
Mar 31, 2022 575,000.00
Dec 31, 2021 354,000.00
Sep 30, 2021 185,000.00
API Access

Celldex Therapeutics, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLDX&period=max&api_key=YOUR_API_KEY